University of Virginia Medical Center Joins National Study Analyzing COVID-19 Treatments
April 12, 2022

UVA Health joins the ACTIV-6 study, sponsored by the National Institute of Health, in pursuit for better therapeutic options for their mild COVID-19 patients. The ACTIV-6 study is investigating the efficacy of fluvoxamine and ivermectin for COVID-19.

Be the First to Know

Sign up to get updates when we add new off-label treatments, articles, videos, and clinical trials!